title: Can propranolol be a viable option for the treatment of small-for-size syndrome?
authors.forename: Young-Dong
authors.initials: YD
authors.lastname: Yu
authors.forename: Dong-Sik
authors.initials: DS
authors.lastname: Kim
authors.forename: Geon-Young
authors.initials: GY
authors.lastname: Byun
authors.forename: Sung-Ock
authors.initials: SO
authors.lastname: Seo
mesh_terms: D000328:Adult; D049628:Body Size; D005260:Female; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects / Q000379:methods*; D009929:Organ Size; D011183:Postoperative Complications / Q000188:drug therapy*; D011433:Propranolol / Q000008:administration & dosage*; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D014665:Vasodilator Agents; D011433:Propranolol